Neurodegeneration in glaucoma and alzheimer's disease

Recent Advances in Ophthalmology Research

Volumn , Issue , 2013, Pages 59-80

  Park, Stanley ^a   Ou, Yvonne ^b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer disease; Compartmentalized neurodegeneration; Dendritic, and axonal degeneration; Glaucoma; Synaptic

Indexed keywords

EID: 84895396634     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (110)

1. Visual Impairment and Blindness Fact Sheet No282. World Health Organization; 2012; Available from: http://www.who.int/mediacentre /factsheets/fs282/en/.
2. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. The British journal of ophthalmology. 2006;90(3):262-7. Epub 2006/02/21.
3. Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Archives of ophthalmology. 1991;109(8):1090-5. Epub 1991/08/01.
4. Leske MC, Connell AM, Wu SY, Hyman LG, Schachat AP. Risk factors for open-angle glaucoma. The Barbados Eye Study. Archives of ophthalmology. 1995;113(7):918-24. Epub 1995/07/01.
5. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. American journal of ophthalmology. 1998;126(4):498-505. Epub 1998/10/21.
6. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Archives of ophthalmology. 2002;120(6):714-20; discussion 829-30. Epub 2002/06/07.
7. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Archives of ophthalmology. 2002;120(6):701-13; discussion 829-30. Epub 2002/06/07.
8. Kerrigan-Baumrind LA, Quigley HA, Pease ME, Kerrigan DF, Mitchell RS. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Investigative ophthalmology and visual science. 2000;41(3):741-8. Epub 2000/03/11.
9. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiology of aging. 1997;18(4 Suppl):S1-2. Epub 1997/07/01.
10. Braak H, Braak E, Bohl J. Staging of Alzheimer-related cortical destruction. European neurology. 1993;33(6):403-8. Epub 1993/01/01.
11. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41(4):479-86. Epub 1991/04/01.
12. Wimo A, Prince M. World Alzheimer Report 2010: The Global Economic Impact of Dementia (London: Alzheimer's Disease International). 2010:1-56.
13. Okie S. Confronting Alzheimer's disease. The New England journal of medicine. 2011;365(12):1069-72. Epub 2011/10/14.
14. Chandra V, Bharucha NE, Schoenberg BS. Conditions associated with Alzheimer's disease at death: case-control study. Neurology. 1986;36(2):209-11. Epub 1986/02/01.
15. Bayer AU, Ferrari F, Erb C. High occurrence rate of glaucoma among patients with Alzheimer's disease. European neurology. 2002;47(3):165-8. Epub 2002/03/27.
16. Tamura H, Kawakami H, Kanamoto T, Kato T, Yokoyama T, Sasaki K, et al. High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. Journal of the neurological sciences. 2006;246(1-2):79-83. Epub 2006/03/28.
17. Kessing LV, Lopez AG, Andersen PK, Kessing SV. No increased risk of developing Alzheimer disease in patients with glaucoma. Journal of glaucoma. 2007;16(1):47-51. Epub 2007/01/17.
18. Ou Y, Grossman DS, Lee PP, Sloan FA. Glaucoma, Alzheimer disease and other dementia: a longitudinal analysis. Ophthalmic epidemiology. 2012;19(5):285-92. Epub 2012/09/18.
19. Bayer AU, Ferrari F. Severe progression of glaucomatous optic neuropathy in patients with Alzheimer's disease. Eye (Lond). 2002;16(2):209-12. Epub 2002/05/04.
20. Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci MG, Pierelli F. Morphological and functional retinal impairment in Alzheimer's disease patients. Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology. 2001;112(10):1860-7. Epub 2001/10/12.
21. McKee AC, Au R, Cabral HJ, Kowall NW, Seshadri S, Kubilus CA, et al. Visual association pathology in preclinical Alzheimer disease. Journal of neuropathology and experimental neurology. 2006;65(6):621-30. Epub 2006/06/20.
22. Leuba G, Saini K. Pathology of subcortical visual centres in relation to cortical degeneration in Alzheimer's disease. Neuropathology and applied neurobiology. 1995;21(5):410-22. Epub 1995/10/01.
23. Armstrong RA. Visual field defects in Alzheimer's disease patients may reflect differential pathology in the primary visual cortex. Optometry and vision science: official publication of the American Academy of Optometry. 1996;73(11):677-82. Epub 1996/11/01.
24. Masliah E, Terry R. The role of synaptic proteins in the pathogenesis of disorders of the central nervous system. Brain Pathol. 1993;3(1):77-85. Epub 1993/01/01.
25. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Annals of neurology. 1991;30(4):572-80. Epub 1991/10/01.
26. Scheff SW, DeKosky ST, Price DA. Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiology of aging. 1990;11(1):29-37. Epub 1990/01/01.
27. Masliah E, Terry RD, DeTeresa RM, Hansen LA. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neuroscience letters. 1989;103(2):234-9. Epub 1989/08/28.
28. DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Annals of neurology. 1990;27(5):457-64. Epub 1990/05/01.
29. Ramsden M, Henderson Z, Pearson HA. Modulation of Ca2+ channel currents in primary cultures of rat cortical neurones by amyloid beta protein (1-40) is dependent on solubility status. Brain research. 2002;956(2):254-61. Epub 2002/11/26.
30. Plant LD, Boyle JP, Smith IF, Peers C, Pearson HA. The production of amyloid beta peptide is a critical requirement for the viability of central neurons. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2003;23(13):5531-5. Epub 2003/07/05.
31. Reinhard C, Hebert SS, De Strooper B. The amyloid-beta precursor protein: integrating structure with biological function. The EMBO journal. 2005;24(23):3996-4006. Epub 2005/10/28.
32. Spires TL, Meyer-Luehmann M, Stern EA, McLean PJ, Skoch J, Nguyen PT, et al. Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2005;25(31):7278-87. Epub 2005/08/05.
33. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 1995;373(6514):523-7. Epub 1995/02/09.
34. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 1996;274(5284):99-102. Epub 1996/10/04.
35. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, et al. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2000;20(11):4050-8. Epub 2000/05/20.
36. Tsai J, Grutzendler J, Duff K, Gan WB. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nature neuroscience. 2004;7(11):1181-3. Epub 2004/10/12.
37. Moolman DL, Vitolo OV, Vonsattel JP, Shelanski ML. Dendrite and dendritic spine alterations in Alzheimer models. Journal of neurocytology. 2004;33(3):377-87. Epub 2004/10/12.
38. Spires-Jones TL, Meyer-Luehmann M, Osetek JD, Jones PB, Stern EA, Bacskai BJ, et al. Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model. The American journal of pathology. 2007;171(4):1304-11. Epub 2007/08/25.
39. Kawahara M, Kuroda Y. Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis. Brain research bulletin. 2000;53(4):389-97. Epub 2001/01/04.
40. Valincius G, Heinrich F, Budvytyte R, Vanderah DJ, McGillivray DJ, Sokolov Y, et al. Soluble amyloid beta-oligomers affect dielectric membrane properties by bilayer insertion and domain formation: implications for cell toxicity. Biophysical journal. 2008;95(10):4845-61. Epub 2008/06/03.
41. Renner M, Lacor PN, Velasco PT, Xu J, Contractor A, Klein WL, et al. Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5. Neuron. 2010;66(5):739-54. Epub 2010/06/16.
42. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, et al. APP processing and synaptic function. Neuron. 2003;37(6):925-37. Epub 2003/04/03.
43. Wei W, Nguyen LN, Kessels HW, Hagiwara H, Sisodia S, Malinow R. Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nature neuroscience. 2010;13(2):190-6. Epub 2009/12/29.
44. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, et al. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron. 2006;52(5):831-43. Epub 2006/12/06.
45. Nimmrich V, Grimm C, Draguhn A, Barghorn S, Lehmann A, Schoemaker H, et al. Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2008;28(4):788-97. Epub 2008/01/25.
46. Dixit R, Ross JL, Goldman YE, Holzbaur EL. Differential regulation of dynein and kinesin motor proteins by tau. Science. 2008; 319(5866):1086-9. Epub 2008/01/19.
47. Mandelkow EM, Stamer K, Vogel R, Thies E, Mandelkow E. Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiology of aging. 2003;24(8):1079-85. Epub 2003/12/04.
48. Fulga TA, Elson-Schwab I, Khurana V, Steinhilb ML, Spires TL, Hyman BT, et al. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nature cell biology. 2007;9(2):139-48. Epub 2006/12/26.
49. Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron. 2007;53(3):337-51. Epub 2007/02/03.
50. Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron. 2010;68(6):1067-81. Epub 2010/12/22.
51. Chin J, Palop JJ, Puolivali J, Massaro C, Bien-Ly N, Gerstein H, et al. Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2005;25(42):9694-703. Epub 2005/10/21.
52. Tu W, Xu X, Peng L, Zhong X, Zhang W, Soundarapandian MM, et al. DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell. 2010;140(2):222-34. Epub 2010/02/10.
53. Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, et al. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. The Journal of neuroscience :the official journal of the Society for Neuroscience. 2007;27(11):2846-57. Epub 2007/03/16.
54. Yoneda S, Hara H, Hirata A, Fukushima M, Inomata Y, Tanihara H. Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases. Japanese journal of ophthalmology. 2005;49(2):106-8. Epub 2005/04/20.
55. McKinnon SJ. Glaucoma: ocular Alzheimer's disease? Frontiers in bioscience: a journal and virtual library. 2003;8:s1140-56. Epub 2003/09/06.
56. Kipfer-Kauer A, McKinnon SJ, Frueh BE, Goldblum D. Distribution of amyloid precursor protein and amyloid-beta in ocular hypertensive C57BL/6 mouse eyes. Current eye research. 2010;35(9):828-34. Epub 2010/08/28.
57. Guo L, Salt TE, Luong V, Wood N, Cheung W, Maass A, et al. Targeting amyloid-beta in glaucoma treatment. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(33):13444-9. Epub 2007/08/09.
58. Gupta N, Fong J, Ang LC, Yucel YH. Retinal tau pathology in human glaucomas. Canadian journal of ophthalmology Journal canadien d'ophtalmologie. 2008;43(1):53-60. Epub 2008/01/26.
59. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2007;27(11):2866-75. Epub 2007/03/16.
60. Fu QL, Li X, Shi J, Xu G, Wen W, Lee DH, et al. Synaptic degeneration of retinal ganglion cells in a rat ocular hypertension glaucoma model. Cellular and molecular neurobiology. 2009;29(4):575-81. Epub 2009/01/28.
61. Georgiou AL, Guo L, Cordeiro MF, Salt TE. Changes in NMDA receptor contribution to synaptic transmission in the brain in a rat model of glaucoma. Neurobiology of disease. 2010;39(3):344-51. Epub 2010/05/11.
62. Crish SD, Sappington RM, Inman DM, Horner PJ, Calkins DJ. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(11):5196-201. Epub 2010/03/03.
63. Ahmed F, Brown KM, Stephan DA, Morrison JC, Johnson EC, Tomarev SI. Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure. Investigative ophthalmology and visual science. 2004;45(4):1247-58. Epub 2004/03/24.
64. Kim HS, Park CK. Retinal ganglion cell death is delayed by activation of retinal intrinsic cell survival program. Brain research. 2005;1057(1-2):17-28. Epub 2005/09/06.
65. Kuehn MH, Kim CY, Ostojic J, Bellin M, Alward WL, Stone EM, et al. Retinal synthesis and deposition of complement components induced by ocular hypertension. Experimental eye research. 2006;83(3):620-8. Epub 2006/05/09.
66. Stasi K, Nagel D, Yang X, Wang RF, Ren L, Podos SM, et al. Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Investigative ophthalmology and visual science. 2006;47(3):1024-9. Epub 2006/03/01.
67. Steele MR, Inman DM, Calkins DJ, Horner PJ, Vetter ML. Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Investigative ophthalmology and visual science. 2006;47(3):977-85. Epub 2006/03/01.
68. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131(6):1164-78. Epub 2007/12/18.
69. Weber AJ, Chen H, Hubbard WC, Kaufman PL. Experimental glaucoma and cell size, density, and number in the primate lateral geniculate nucleus. Investigative ophthalmology and visual science. 2000;41(6):1370-9. Epub 2000/05/08.
70. Weber AJ, Harman CD. Structure-function relations of parasol cells in the normal and glaucomatous primate retina. Investigative ophthalmology and visual science. 2005;46(9):3197-207. Epub 2005/08/27.
71. Shou T, Liu J, Wang W, Zhou Y, Zhao K. Differential dendritic shrinkage of alpha and beta retinal ganglion cells in cats with chronic glaucoma. Investigative ophthalmology and visual science. 2003;44(7):3005-10. Epub 2003/06/26.
72. Morgan JE, Uchida H, Caprioli J. Retinal ganglion cell death in experimental glaucoma. The British journal of ophthalmology. 2000;84(3):303-10. Epub 2000/02/24.
73. Gupta N, Ly T, Zhang Q, Kaufman PL, Weinreb RN, Yucel YH. Chronic ocular hypertension induces dendrite pathology in the lateral geniculate nucleus of the brain. Experimental eye research. 2007;84(1):176-84. Epub 2006/11/11.
74. Watts RJ, Hoopfer ED, Luo L. Axon pruning during Drosophila metamorphosis: evidence for local degeneration and requirement of the ubiquitin-proteasome system. Neuron. 2003;38(6):871-85. Epub 2003/06/24.
75. Kuo CT, Zhu S, Younger S, Jan LY, Jan YN. Identification of E2/E3 ubiquitinating enzymes and caspase activity regulating Drosophila sensory neuron dendrite pruning. Neuron. 2006;51(3):283-90. Epub 2006/08/02.
76. Wagner MC, Pfister KK, Bloom GS, Brady ST. Copurification of kinesin polypeptides with microtubule-stimulated Mg-ATPase activity and kinetic analysis of enzymatic properties. Cell motility and the cytoskeleton. 1989;12(4):195-215. Epub 1989/01/01.
77. Elluru RG, Bloom GS, Brady ST. Fast axonal transport of kinesin in the rat visual system: functionality of kinesin heavy chain isoforms. Molecular biology of the cell. 1995;6(1):21-40. Epub 1995/01/01.
78. Masliah E, Hansen L, Albright T, Mallory M, Terry RD. Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease. Acta neuropathologica. 1991;81(4):428-33. Epub 1991/01/01.
79. Dessi F, Colle MA, Hauw JJ, Duyckaerts C. Accumulation of SNAP-25 immunoreactive material in axons of Alzheimer's disease. Neuroreport. 1997;8(17):3685-9. Epub 1998/01/14.
80. Praprotnik D, Smith MA, Richey PL, Vinters HV, Perry G. Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease. Acta neuropathologica. 1996;91(3):226-35. Epub 1996/01/01.
81. Pease ME, McKinnon SJ, Quigley HA, Kerrigan-Baumrind LA, Zack DJ. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Investigative ophthalmology and visual science. 2000;41(3):764-74. Epub 2000/03/11.
82. Coleman M. Molecular signaling how do axons die? Advances in genetics. 2011;73:185-217. Epub 2011/02/12.
83. Hall AM, Roberson ED. Mouse models of Alzheimer's disease. Brain research bulletin. 2012;88(1):3-12. Epub 2011/12/07.
84. Kanaan NM, Pigino GF, Brady ST, Lazarov O, Binder LI, Morfini GA. Axonal degeneration in Alzheimer's disease: When signaling abnormalities meet the axonal transport system. Experimental neurology. 2012. Epub 2012/06/23.
85. Pigino G, Morfini G, Atagi Y, Deshpande A, Yu C, Jungbauer L, et al. Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(14):5907-12. Epub 2009/03/27.
86. Decker H, Lo KY, Unger SM, Ferreira ST, Silverman MA. Amyloidbeta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2010;30(27):9166-71. Epub 2010/07/09.
87. Rui Y, Tiwari P, Xie Z, Zheng JQ. Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2006;26(41):10480-7. Epub 2006/10/13.
88. LaPointe NE, Morfini G, Pigino G, Gaisina IN, Kozikowski AP, Binder LI, et al. The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity. Journal of neuroscience research. 2009;87(2):440-51. Epub 2008/09/18.
89. Sperber BR, Leight S, Goedert M, Lee VM. Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells. Neuroscience letters. 1995;197(2):149-53. Epub 1995/09/08.
90. Kanaan NM, Morfini G, Pigino G, LaPointe NE, Andreadis A, Song Y, et al. Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport. Neurobiology of aging. 2012;33(4):826 e15-30. Epub 2011/07/29.
91. Takashima A, Murayama M, Murayama O, Kohno T, Honda T, Yasutake K, et al. Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proceedings of the National Academy of Sciences of the United States of America. 1998;95(16):9637-41. Epub 1998/08/05.
92. Pigino G, Morfini G, Pelsman A, Mattson MP, Brady ST, Busciglio J. Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2003;23(11):4499-508. Epub 2003/06/14.
93. Song MS, Saavedra L, de Chaves EI. Apoptosis is secondary to nonapoptotic axonal degeneration in neurons exposed to Abeta in distal axons. Neurobiology of aging. 2006;27(9):1224-38. Epub 2005/08/27.
94. Vosler PS, Brennan CS, Chen J. Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Molecular neurobiology. 2008;38(1):78-100. Epub 2008/08/08.
95. Morgan JE, Jeffery G, Foss AJ. Axon deviation in the human lamina cribrosa. The British journal of ophthalmology. 1998;82(6):680-3. Epub 1998/11/03.
96. Howell GR, Libby RT, Jakobs TC, Smith RS, Phalan FC, Barter JW, et al. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. The Journal of cell biology. 2007;179(7):1523-37. Epub 2007/12/26.
97. Osborne NN, Melena J, Chidlow G, Wood JP. A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma. The British journal of ophthalmology. 2001;85(10):1252-9. Epub 2001/09/25.
98. Hernandez MR, Miao H, Lukas T. Astrocytes in glaucomatous optic neuropathy. Progress in brain research. 2008;173:353-73. Epub 2008/10/22.
99. Libby RT, Li Y, Savinova OV, Barter J, Smith RS, Nickells RW, et al. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS genetics. 2005;1(1):17-26. Epub 2005/08/17.
100. Knoferle J, Koch JC, Ostendorf T, Michel U, Planchamp V, Vutova P, et al. Mechanisms of acute axonal degeneration in the optic nerve in vivo. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(13):6064-9. Epub 2010/03/17.
101. Koch JC, Knoferle J, Tonges L, Ostendorf T, Bahr M, Lingor P. Acute axonal degeneration in vivo is attenuated by inhibition of autophagy in a calcium-dependent manner. Autophagy. 2010;6(5):658-9. Epub 2010/05/12.
102. Tao J, Rolls MM. Dendrites have a rapid program of injury-induced degeneration that is molecularly distinct from developmental pruning. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2011;31(14):5398-405. Epub 2011/04/08.
103. Abramov AY, Scorziello A, Duchen MR. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2007;27(5):1129-38. Epub 2007/02/03.
104. Ward MW, Rego AC, Frenguelli BG, Nicholls DG. Mitochondrial membrane potential and glutamate excitotoxicity in cultured cerebellar granule cells. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2000;20(19):7208-19. Epub 2000/09/29.
105. Feng W, Liu G, Allen PD, Pessah IN. Transmembrane redox sensor of ryanodine receptor complex. The Journal of biological chemistry. 2000;275(46):35902-7. Epub 2000/09/22.
106. Stasi K, Nagel D, Yang X, Ren L, Mittag T, Danias J. Ceruloplasmin upregulation in retina of murine and human glaucomatous eyes. Investigative ophthalmology and visual science. 2007;48(2):727-32. Epub 2007/01/26.
107. Ghanem AA, Arafa LF, El-Baz A. Oxidative stress markers in patients with primary open-angle glaucoma. Current eye research. 2010;35(4):295-301. Epub 2010/04/09.
108. Staal JA, Dickson TC, Gasperini R, Liu Y, Foa L, Vickers JC. Initial calcium release from intracellular stores followed by calcium dysregulation is linked to secondary axotomy following transient axonal stretch injury. Journal of neurochemistry. 2010;112(5):1147-55. Epub 2009/12/09.
109. Sappington RM, Sidorova T, Long DJ, Calkins DJ. TRPV1: contribution to retinal ganglion cell apoptosis and increased intracellular Ca2+ with exposure to hydrostatic pressure. Investigative ophthalmology and visual science. 2009;50(2):717-28. Epub 2008/10/28.
110. Buckingham BP, Inman DM, Lambert W, Oglesby E, Calkins DJ, Steele MR, et al. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2008;28(11):2735-44. Epub 2008/03/14.